Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2026-02-02 @ 4:06 PM
Study NCT ID:
NCT03128359
Status:
COMPLETED
Last Update Posted:
2024-01-09
First Post:
2017-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant
Sponsor:
City of Hope Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Leukemia | View |
| None | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | View |
| None | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | View |
| None | Diffuse Large B-Cell Lymphoma | View |
| None | Follicular Lymphoma | View |
| None | Graft Versus Host Disease | View |
| None | Hodgkin Lymphoma | View |
| None | Mantle Cell Lymphoma | View |
| None | Marginal Zone Lymphoma | View |
| None | Myelodysplastic Syndrome | View |
| None | Myeloproliferative Neoplasm | View |
| None | Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes | View |
| None | Recurrent Plasma Cell Myeloma | View |
| None | Refractory Plasma Cell Myeloma | View |
| None | Secondary Myelodysplastic Syndrome | View |
Keywords: